IT's ₹25K crore market value gain mirrors pharma's loss as Nifty falls
Indian markets moved lower.
· Business Standard Mkts
IT and FMCG stocks' rally failed to push up a broader market that fell 0.44 per cent on Wednesday, dragged by pharma stocks even as it gained the previous session.
The analysis
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Market context
- A market-wide development: it reaches beyond any single stock.
- Sectors in the story: Pharma & Healthcare and FMCG.
Pharma & Healthcare
1M -0.6% · 3M -0.9%
FMCG
1M -4.9% · 3M -10.7%
Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Pharma company Gufic buys Lodha Avalon duplex in Juhu for ₹236 crore
ITC Q2 Results Preview: Profit seen falling nearly 30% YoY as cigarette tax hikes bite
Nifty IT’s 18% rally may mark a durable leadership cycle; 35,000 next: LKP's Vatsal Bhuva
After Welcomhotel Manesar, ITC Hotels expands Delhi-NCR presence with 105-key Fortune Select Greater Noida